272 Capital’s Definitive Healthcare DH Stock Holding History

272 Capital’s Portfolio DH Stock Details DH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-107,531	Closed	-$311K	–	19
2025 Q1	$311K	Sell	107,531 -570,409	-84%	-$2.31M	0.82%	19
2024 Q4	$2.79M	Sell	677,940 -436,140	-39%	-$1.91M	2.63%	15
2024 Q3	$4.98M	Buy	1,114,080 +476,766	+75%	+$2.24M	2.85%	12
2024 Q2	$3.48M	Buy	+637,314	New	+$4.01M	1.74%	22

Other funds holding DH

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

272 Capital's DH Position: Q2 2025 in Review

272 Capital sold out of Definitive Healthcare (DH) in Q2 2025, closing a stake of 107,531 shares — an estimated $311K sold.

272 Capital first reported a position in DH in Q2 2024 and held it in 4 quarters. The position peaked at $4.98M in Q3 2024. 121 funds tracked by Wall St. Rank hold DH as of Q2 2025.

272 Capital reported no remaining Definitive Healthcare position as of Q2 2025 after selling out during the quarter.
272 Capital sold 107,531 Definitive Healthcare shares in Q2 2025, an estimated $311K.
272 Capital first reported a position in Definitive Healthcare in Q2 2024 and held it in 4 quarters.
272 Capital's Definitive Healthcare position peaked at $4.98M in Q3 2024.
121 funds tracked by Wall St. Rank held Definitive Healthcare as of Q2 2025.

Based on 272 Capital's 13F filing for Q2 2025, filed 14 Aug 2025.